throbber
Trials@uspto.gov Paper No. 10
`571-272-7822
`
` Entered: February 7, 2019
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`THERMO FISHER SCIENTIFIC, INC.,
`Petitioner,
`
`v.
`
`THE REGENTS OF THE UNIVERSITY OF CALIFORNIA,
`Patent Owner.
`____________
`
`Case IPR2018-01367
`Patent 8,835,113 B2
`____________
`
`Before ERICA A. FRANKLIN, MICHELLE N. ANKENBRAND, and
`JOHN E. SCHNEIDER, Administrative Patent Judges.
`
`FRANKLIN, Administrative Patent Judge.
`
`DECISION
`Denying Institution of Inter Partes Review
`35 U.S.C. § 314(a)
`
`

`

`IPR2018-01367
`Patent 8,835,113 B2
`
`
` INTRODUCTION
`Thermo Fisher Scientific, Inc. (“Petitioner”) filed a Petition requesting
`an inter partes review of claims 1, 3–5, 7, 20, 22, and 25–27 of U.S. Patent
`No. 8,835,113 B2 (Ex. 1001, “the ’113 patent”). Paper 1 (“Pet.”). The
`Regents of the University of California (“Patent Owner”) filed a Preliminary
`Response to the Petition. Paper 7 (“Prelim. Resp.”).
`We have authority under 35 U.S.C. § 314 to determine whether to
`institute an inter partes review. Upon considering the Petition and the
`Preliminary Response, along with the circumstances involved in this case,
`we determine that Petitioner has not shown a reasonable likelihood that it
`would prevail in showing the unpatentability of at least one challenged
`claim. Accordingly, we deny the Petition and decline to institute an inter
`partes review.
`
`Related Proceedings
`A.
`Petitioner and Patent Owner identify an ongoing district court
`proceeding involving the ’113 patent: The Regents of the University of
`California et al. v. Affymetrix, Inc. et al., No. 3:17-cv-01394 (CASD).
`Pet. 67; Paper 4, 2. The parties also note that Petitioner has concurrently
`filed a separate petition involving the ’113 patent (IPR2018-01368) and,
`shortly thereafter, filed two petitions involving a related patent, U.S. Patent
`No. 8,110,673 B2 (IPR2018-01369 and IPR2018-01370). Pet. 67; Paper 4,
`1–2.
`
`The ’113 Patent
`B.
`The ’113 patent relates to methods for assaying a sample for an
`aggregant using an aggregation sensor. Ex. 1001, 1:32–34. “An aggregant
`to be assayed may be a target biomolecule (e.g., a polysaccharide, a
`
`2
`
`
`
`

`

`IPR2018-01367
`Patent 8,835,113 B2
`
`polynucleotide, a peptide, a protein, etc.).” Id. at 15:55–58. “The
`aggregation sensor comprises a component that can bind to an aggregant or
`class of aggregants.” Id. at 10:10–12. The Specification explains that
`“[c]onjugated polymers have proven useful as light gathering molecules in a
`variety of settings.” Id. at 1:49–50. In particular, “[w]ater-soluble
`conjugated polymers such as cationic conjugated polymers (CCPs) have
`been used in bioassays to improve detection sensitivity and provide new
`routes of selectivity in analyzing biomolecules.” Id. at 1:51–55. The
`molecular structure of those molecules “allows for a collective response and,
`therefore, optical amplification of fluorescent signals.” Id. at 2:33–37.
`Specifically, “[t]he large number of optically active units along the polymer
`chain increases the probability of light absorption, relative to small molecule
`counterparts.” Id. at 2:37–39. The presence of target DNA in a sample may
`be detected upon delivery of excitations to fluorophores, using facile
`fluorescence resonance energy transfer (FRET). Id. at 2:39–42.
`The Specification explains that “[r]ecent studies indicate that energy
`transfer between segments in conjugated polymers may be substantially
`more important than along the backbone” and that external perturbations that
`decrease the elongation of the backbone or bring its segments closer together
`may be used to modify emissive properties of the polymer in solution. Id. at
`2:46–49. Based on that information, the Specification states that the
`inventors recognized “a small number of fluorescent units within a polymer
`sequence could be activated by structural changes that compressed or
`aggregated the polymer chains to ultimately change the emission color” and
`then designed a cationic conjugated polymer structure in accordance with
`that principle. Id. at 2:50–55. According to the Specification,
`
`
`
`
`3
`
`

`

`IPR2018-01367
`Patent 8,835,113 B2
`
`“[e]lectrostatic complexation with negatively charged DNA can be used to
`reduce the average intersegment distance. When combined with a
`fluorophore labeled peptide nucleic acid (PNA) strand, the polymer can be
`used to design a three color DNA detection assay.” Id. at 2:55–60.
`Illustrative Claim
`C.
`Claim 1 of the ’113 patent, reproduced below, is the only independent
`claim, and is illustrative of the claimed subject matter.
`1. A method of assaying a sample for an aggregant, the
`method comprising:
`(a) combining the sample with an aggregation sensor
`comprising
`(i) a polymer comprising a plurality of first optically
` active units forming a conjugated system, having a
` first absorption wavelength at which the first optically
` active units absorb light to form an excited state that
` can emit light of a first emission wavelength, and a
` plurality of solubilizing functionalities; and
`
` (ii) one or more second optically active units that can
`
` receive energy from the excited state of the first optically
`
` active unit;
`
` wherein said aggregation sensor comprises at least three
`
` first optically active units per second optically active unit
`
` and the second optically active unit is grafted to the
`
` conjugated system;
` (b) contacting the sample with light of the first absorption
` wavelength; and
` (c) detecting the optical properties of the aggregation sensor
` to assay the sample for the aggregant.
`
`
`D.
`
`The Asserted Grounds of Unpatentability
`
`Petitioner challenges the patentability of claims 1, 3–5, 7, 20, 22, and
`25–27 of the ’113 patent on the following grounds:
`
`
`
`
`4
`
`

`

`IPR2018-01367
`Patent 8,835,113 B2
`
`
`Claim(s)
`1, 20, 22, 25, and 26
`
`1, 3–5, 7, and 27
`
`Basis
`§ 103(a)
`
`§ 103(a)
`
`References
`Hou1 and Inganas2
`
`Hou, Bazan,3 and the Handbook4
`
`Petitioner also relies upon the Declaration of Kirk S. Schanze, Ph.D.
`(Ex. 1002).5 Patent Owner relies upon the Declaration of Dwight Seferos,
`Ph.D. (Ex. 2008).
`
` ANALYSIS
`Claim Construction
`A.
`In an inter partes review, the Board interprets claim terms in an
`unexpired patent according to the broadest reasonable construction in light
`of the specification of the patent in which they appear. 37 C.F.R.
`§ 42.100(b); Cuozzo Speed Techs., LLC v. Lee, 136 S. Ct. 2131, 2142 (2016)
`(affirming applicability of broadest reasonable construction standard to inter
`partes review proceedings).6 Under that standard, and absent any special
`
`
`
` 1
`
` Hou et al., Novel red-emitting fluorene-based copolymers, 12 J. MATER.
`CHEM. 2887-2892 (2002) (“Hou”) (Ex. 1007).
`2 Inganas et al., WO 2003/096016 A1, published Nov. 20, 2003 (“Inganas”)
`(Ex. 1006).
`3 Bazan et al., WO 2004/001379 A2, published Dec. 31, 2003 (“Bazan”)
`(Ex. 1033).
`4 Haugland, HANDBOOK OF FLUORESCENT PROBES AND RESEARCH
`PRODUCTS, 9th ed., Molecular Probes (2002) (“the Handbook”) (Ex. 1005).
`5 Petitioner includes the letters “TFS” with its exhibit numbers. We do not
`adopt that practice in this decision.
`6 The Office recently changed the claim construction standard to be
`employed in an inter partes review. See Changes to the Claim Construction
`Standard for Interpreting Claims in Trial Proceedings Before the Patent
`Trial and Appeal Board, 83 Fed. Reg. 51340 (October 11, 2018). However,
`
`5
`
`
`

`

`IPR2018-01367
`Patent 8,835,113 B2
`
`definitions, we give claim terms their ordinary and customary meaning, as
`would be understood by one of ordinary skill in the art at the time of the
`invention. In re Translogic Tech., Inc., 504 F.3d 1249, 1257 (Fed. Cir.
`2007); Trivascular, Inc. v. Samuels, 812 F.3d 1056, 1062 (Fed. Cir. 2016)
`(“Under a broadest reasonable interpretation, words of the claim must be
`given their plain meaning, unless such meaning is inconsistent with the
`specification and prosecution history.”).
`Petitioner proposes that we adopt certain district court claim
`constructions for a number of claim terms. Pet. 15–17. In doing so,
`Petitioner provides the proposed constructions without any discussion or
`reference to the Specification in support of them. In any event, we
`determine that construction of those claim terms is not necessary for purpose
`of this Decision. See Vivid Techs., Inc. v. Am. Sci. & Eng’g, Inc., 200 F.3d
`795, 803 (Fed. Cir. 1999) (only terms that are in controversy need to be
`construed, and only to the extent necessary to resolve the controversy).
`B.
`Level of Ordinary Skill in the Art
`The level of skill in the art is a factual determination that provides a
`primary guarantee of objectivity in an obviousness analysis. Al-Site Corp. v.
`VSI Int’l Inc., 174 F.3d 1308, 1324 (Fed. Cir. 1999) (citing Graham v. John
`Deere Co., 383 U.S. 1, 17–18 (1966); Ryko Mfg. Co. v. Nu-Star, Inc., 950
`F.2d 714, 718 (Fed. Cir. 1991)).
`
`
`
`based on the filing date of the Petition in this proceeding, the applicable
`claim construction standard remains as set forth in 37 C.F.R. § 42.100(b)
`(2016).
`
`
`
`6
`
`

`

`IPR2018-01367
`Patent 8,835,113 B2
`
`
`According to Petitioner, a person of ordinary skill in the art at the time
`of the invention would have had “knowledge of the scientific literature
`concerning methods of synthesizing fluorescent conjugated polymers and
`using these polymers in biosensors.” Pet. 7 (citing Ex. 1002 ¶ 11). In
`particular, Petitioner asserts,
`Here, a POSA would typically have had (i) a Ph.D. in Chemistry,
`or a related field in the chemical sciences, and have at least about
`two years of experience in chemical synthesis and application of
`fluorescent conjugated polymers; or (ii) a Master's degree in the
`same fields with at least about five years of the same experience.
`Also, a POSA may have worked as part of a multidisciplinary
`team and drawn upon not only his/her own skills, but of others
`on the team, e.g., to solve a given problem. For example, a
`biochemist, molecular biologist and a clinician specializing in
`detection of biological molecules may have been part of a team.
`
`
`Id. (citing Ex. 1002 ¶ 12).
` Patent Owner asserts that a person of ordinary skill in the art “would
`possess a Ph.D. in chemistry or related fields and some experience with
`fluorescence or, alternatively, a master’s degree in chemistry or related
`fields and industry experience in the field of biological detection systems
`and/or the use and design of fluorescent dyes.” Prelim. Resp. 4–5.
`We note that those descriptions are fairly the same, except for
`Petitioner’s description additionally recognizing a member of an unspecified
`multidisciplinary team as a person of ordinary skill in the art. Insofar as that
`additional description is vague, we decline to adopt it. Instead, for purposes
`of this Decision, we determine that the remaining portion of Petitioner’s
`description of the level of ordinary skill in the art is sufficiently detailed and
`one that the current record supports. Thus, we recognize, for purposes of
`this Decision, a person of ordinary skill in the art as one having either a
`
`7
`
`
`

`

`IPR2018-01367
`Patent 8,835,113 B2
`
`Ph.D. in Chemistry, or a related field in the chemical sciences, and having at
`least about two years of experience in chemical synthesis and application of
`fluorescent conjugated polymers, or a Master's degree in the same fields
`with at least about five years of the same experience.
`Moreover, we have reviewed the credentials of Drs. Schanze
`(Ex. 1027) and Seferos (Ex. 2009) and, at this stage in the proceeding,
`consider them to be qualified to provide their opinions on the level of skill
`and the knowledge of a person of ordinary skill in the art at the time of the
`invention. We also note that the applied prior art reflects the appropriate
`level of skill at the time of the claimed invention. See Okajima v. Bourdeau,
`261 F.3d 1350, 1355 (Fed. Cir. 2001).
`C. Obviousness over Hou and Inganas
`Petitioner asserts that claims 1, 20, 22, 25, and 26 would have been
`obvious over the combination of Hou and Inganas. Pet. 18–46. Patent
`Owner disagrees. Prelim. Resp. 5–51.
`1. Hou
`Hou is a journal article discussing the synthesis of a series of novel
`red-emitting fluorene-based conjugated copolymers. Ex. 1007. Hou
`explains that “electrolumine[s]cent polymers have attracted great attention
`due to their possible utilization in flat panel displays.” Id. at 2887.7 In
`particular, Hou notes that polyfluorenes are “promising new materials for
`
`
`
` 7
`
` We refer to the original page numbering provided in each reference for
`citations to our statements. However, when setting forth Petitioner’s
`arguments and citations, we quote the page numbering in the manner
`Petitioner cites, which, for the most part, refers to page numbers that
`Petitioner added to the references.
`
`
`
`8
`
`

`

`IPR2018-01367
`Patent 8,835,113 B2
`
`light-emitting diodes because of their thermal and chemical stability and
`exceptionally high fluorescence quantum yields [] in thin solid films.” Id.
`Although polyfluorene homopolymers have large bandgaps and emit blue
`light, Hou explains that emission color can be desirably “tuned over the
`entire visible region by incorporating narrow band-gap comonomers into the
`polyfluorene backbone.” Id. According to Hou, it is expected that “the
`narrow band-gap unit functions as an exciton trap which allows efficient
`intramolecular energy transfer from the fluorene segment to the DBT unit,”
`giving rise to red light emission. Id. at 2887, 2889.
`
`Hou describes preparing the copolymers from 2,7-dibromo-9,9-
`dioctylfluorene (DOF), 2,7-bis(4,4,5,5-tetramethyl-l,3,2-dioxaborolan-2-yl)-
`9,9-dioctylfluorene and narrow band gap comonomer 4,7-bis(5-bromo-2-
`thienyl)-2,1,3-benzothiadiazole (DBT) using palladium catalyzed Suzuki
`coupling methods. Id. at 2888. Hou explains that the “n-octyl substituents
`in the 9-position of fluorine were employed to improve the solubility of the
`resulting copolymers.” Id. The resulting polymers were readily soluble in
`conventional organic solvents, e.g., toluene, chloroform, and tetrahydro-
`furan. Id. The photoluminescent (PL) spectra of the polymers in thin films
`and in CHCl3 solution, produced by excitation, were analyzed. Id. at 2889.
`Electroluminescent properties from a single layer device fabricated with
`copolymer with 15% DBT content were also determined. Id. at 2891. Hou
`concludes that “[t]he efficient energy transfer due to exciton trapping on
`narrow band-gap DBT sites has been observed. Polyfluorene fluorescence is
`quenched completely at DBT concentrations as low as 1% in the solid state
`film. All of the copolymers emit saturated red color.” Id. Hou “notes also
`that both PL (in solution and in solid films) and EL [electroluminescence]
`
`
`
`
`9
`
`

`

`IPR2018-01367
`Patent 8,835,113 B2
`
`emission are red-shifted with increasing DBT content in polymer chains.”
`Id.
`
`2. Inganas
`Inganas is a PCT Application directed to “methods for detection of
`biomolecular interactions through the detection of alterations of the intra-
`and inter-chain processes in materials based on zwitterionic conjugated
`polyelectrolytes.” Ex. 1006, 1:6–8. Inganas explains that conjugated
`polymers such as poly(thiophene) and poly(pyrrole) are useful as biosensors
`because they are “sensitive to very minor perturbations, due to amplification
`by a collective system response.” Id. at 1:15–18. Inganas states that such
`use of conjugated polymers requires that they are “compatible with aqueous
`environment.” Id. at 1:20–21. Inganas explains that this may be
`accomplished by making conjugated polyelectrolytes. Id. at 1:21–23.
`“[T]he polyelectrolyte comprises copolymers or homopolymers of
`thiophene, pyrrole, aniline, furan, phenylene, vinylene or their substituted
`forms, and preferably the conjugated polyelectrolyte has one or more
`zwitterionic side chain functionalities.” Id. at 3:1–4.
`3. Analysis
`“An obviousness determination requires that a skilled artisan would
`have perceived a reasonable expectation of success in making the invention
`in light of the prior art.” Amgen, Inc. v. F. Hoffman–La Roche Ltd., 580
`F.3d 1340, 1362 (Fed. Cir. 2009). “The reasonable expectation of success
`requirement refers to the likelihood of success in combining references to
`meet the limitations of the claimed invention.” Intelligent Bio-Sys, Inc. v.
`Illumina Cambridge Ltd., 821 F.3d 1359, 1367 (Fed. Cir. 2016). “[O]ne
`must have a motivation to combine accompanied by a reasonable
`
`
`
`
`10
`
`

`

`IPR2018-01367
`Patent 8,835,113 B2
`
`expectation of achieving what is claimed in the patent-at-issue.” Id.
`Petitioner asserts that “Hou and Inganas teach all the elements of
`claim 1.” Pet. 18. In particular, we focus on Petitioner’s reliance on the
`combined teachings of Hou and Inganas to yield the elements of the
`“aggregation sensor” recited in claim 1.
`Petitioner relies on Hou as disclosing a conjugated polymer with a
`plurality of first units, 9,9-dictylfluorene (fluorene), and one or more second
`units, 4,7-di-2-thienyl-2,1,3-benzothiadiazole (DBT). Id. at 19. Petitioner
`relies on Inganas as disclosing the use of conjugated polymers to detect
`interactions between biomolecules by an optical change in the polymer upon
`binding an analyte, wherein the spectral change could be mediated by
`“separation or aggregation of [polymer] chains.” Id. at 22. Specifically,
`Petitioner asserts that Inganas discloses forming conjugated polyelectrolytes
`by appending zwitterionic side-chains to the conjugated polymer. Id. at 21–
`22 (citing Ex. 1002 ¶¶ 67, 70; Ex. 1006, 4:1–4). Petitioner asserts that
`Inganas teaches that the “‘zwitterionic polyelectrolyte[s]’ could
`electrostatically associate with a ‘receptor’ moiety (e.g., antibody or DNA),
`which ‘act[ed] as the recognition site for analytes.” Id. at 22 (citing
`Ex. 1006, 6:16–7:3; Ex. 1002 ¶¶ 67, 74). Petitioner asserts that “Inganas
`taught that this polymer-receptor ‘complex’ would act as a ‘biosensor… for
`detection of molecular interactions’ through a spectral change.” Id. at 22
`(citing Ex. 1006, 9:7–28; Ex. 1002 ¶ 75). Petitioner states that “Inganas
`notes that the ‘the possibility to use [conjugated polymers] as detecting
`elements for biological molecules requires that polymer are [made]
`compatible with aqueous environment,’ via addition of ‘one or more
`zwitterionic side chain functionalities’ (i.e., a plurality of solubilizing
`
`
`
`
`11
`
`

`

`IPR2018-01367
`Patent 8,835,113 B2
`
`functionalities) to the polymer.” Id. at 28 (citing Ex. 1002 ¶¶ 67, 91;
`Ex. 1006, 2:19–21, 4:1–4).
`According to Petitioner and Dr. Schanze, although Hou’s polyfluorene
`copolymers were developed for use in LED devices, a person of skill in the
`art would have had a reason “to use Hou’s conjugated copolymers in
`Inganas’ biosensor” because Hou’s copolymers “showed a color change
`upon aggregation (a concentration increase), just as Inganas wanted.” Pet.
`31 (citing Ex. 1002 ¶¶ 77, 97, 98–109). Further, Petitioner and Dr. Schanze
`assert that a person of skill in the art “would have had reason to render
`copolymers water-soluble in the manner taught by Inganas: by attaching
`solubilizing ‘zwitterionic side chain functionalities’ to Hou’s polymer.” Id.
`at 37 (citing Ex. 1006, 4:1–5; Ex. 1002 ¶ 107). Specifically, Petitioner and
`Dr. Schanze assert that the person of skill would have modified Hou’s
`copolymer because Inganas explained that the zwitterionic side-chains were
`“needed—not only did they make the polymer ‘compatible with aqueous
`environment,’ but also mediated formation of a polymer-receptor complex
`by ‘hydrogen bonding, electrostatic- and non-polar interactions’ with the
`receptor.” Pet. 37; Ex. 1002 ¶ 107.
`Significantly, Petitioner and Dr. Schanze assert that a person of
`ordinary skill in the art it would have had a reasonable expectation of
`success in appending Inganas’ zwitterionic side-chains onto Hou’s
`copolymers to provide conjugated polymers comprising a plurality
`solubilizing functionalities. Pet. 38–40; Ex. 1002 ¶¶ 108, 111–113.
`According to Petitioner and Dr. Schanze, “a POSA would have known how
`to attach two zwitterionic functionalities to each fluorene monomer of Hou’s
`copolymer at position 9 of fluorene.” Pet. 39 (citing Ex. 1002 ¶ 112).
`
`
`
`
`12
`
`

`

`IPR2018-01367
`Patent 8,835,113 B2
`
`Petitioner asserts that “a POSA would have known, given the general
`knowledge in the art, that the 9 position of fluorene is the common place for
`attachment of different functionalities to fluorene polymers.” Id.
`Additionally, Petitioner asserts that it was “standard in this field, according
`to Dr. Schanze, to start with fluorene monomers that are underivatized at
`position 9, and use standard chemical methods to append the desired
`functionalities.” Id. In support, Petitioner and Dr. Schanze refer to Wang8
`as teaching “how to append polycationic functionalities onto fluorene
`monomers at position 9.” Id. at 40 (citing Ex. 1002 ¶ 113; Ex. 1004, 3:2:3–
`4:1:1:1, 4:Scheme 2 (compound 2)). According to Petitioner and
`Dr. Schanze, “[t]he only difference would have been in the last step—
`instead of treating precursor fluorenes corresponding to compounds 11a-c of
`Wang with trimethylamine, a POSA would have treated them with N-t-
`BOC-L-serine.” Id. (citing Ex. 1002 ¶113; Ex. 1004, 4:1:1).
`
`Patent Owner asserts, among other things, that a person of skill in the
`art “would not have been motivated to modify Hou’s polymers as suggested
`by Thermo because such modification would not have been expected to be
`successful.” Prelim. Resp. 47. In particular, Patent Owner asserts that
`Petitioner’s “proposed mechanism for attaching Inganas’ [zwitterionic] side
`chain requires one to ‘start with fluorene monomers that are underivatized at
`position 9, and use standard chemical methods to append the desired
`functionalities.’” Id. at 44 (quoting Pet. 39) (emphasis added by Patent
`
`
`
` 8
`
` Wang et al., Size-Specific Interactions Between Single-and Double-
`Stranded Oligonucleotides and Cationic Water-Soluble Oligofluorenes, 13
`ADV. FUNCT. MATER. 463–467 (2003) (“Wang”) (Ex. 1004).
`
`13
`
`
`

`

`IPR2018-01367
`Patent 8,835,113 B2
`
`Owner). According to Patent Owner, Petitioner has not demonstrated that a
`person of ordinary skill in the art would have had a reasonable expectation
`of successfully doing so “because Hou’s copolymers are not underivatized at
`position 9 and because Inganas, in fact, instructs a POSA to add side chains
`to the thiophene unit, not a fluorene unit like in Hou.” Id. at 44. In that
`regard, Patent Owner asserts that Petitioner has not explained sufficiently
`why a person of ordinary skill in the art would have chosen to add Inganas’
`zwitterionic side chains to the fluorene monomer of Hou’s copolymer and
`not the thiophene unit in the DBT unit of Hou’s copolymer, as suggested by
`Inganas. Id. at 46–47; Ex. 1006, 3:1–4.
`
`Having considered the arguments and evidence, we find Patent
`Owner’s arguments to have merit. In particular, we agree with Patent
`Owner that Petitioner has not adequately demonstrated that a person of
`ordinary skill in the art would have had a reasonable expectation of
`successfully modifying Hou in the manner Petitioner has proposed.
`According to Petitioner, a person of ordinary skill in the art would have
`understood from Inganas that in order for Hou’s copolymers to be useful as
`aggregation sensors in the method Inganas discloses, Hou’s copolymers
`would need to be modified to include zwitterionic side chains. Pet. 37.
`Indeed, Petitioner asserts that Inganas teaches that inclusion of those side
`chains were “needed—not only did they make the polymer ‘compatible with
`aqueous environment,’ but also mediated formation of a polymer-receptor
`complex by ‘hydrogen bonding, electrostatic- and non-polar interactions’
`with the receptor.” Id.; Ex. 1002 ¶ 107. Thus, Petitioner’s combination of
`Hou and Inganas requires, at a minimum, a person of ordinary skill in the art
`to have had a reasonable expectation of successfully appending Inganas’
`
`
`
`
`14
`
`

`

`IPR2018-01367
`Patent 8,835,113 B2
`
`zwitterionic side chain functionalities to Hou’s copolymer.
`According to Petitioner and Dr. Schanze, such modification should be
`performed at position 9 of the fluorene unit. Pet. 39 (citing Ex. 1002 ¶ 112).
`As Patent Owner has demonstrated, Hou discloses that such position already
`includes two C8H17 dioctyl side chains. See Prelim. Resp. 45 (citing
`Ex. 1007, Scheme 1). In proposing its modification to Hou, Petitioner has
`not addressed the presence of those dioctyl side chains at position 9 of the
`fluorene unit in Hou’s copolymer, and thus has not provided any explanation
`regarding whether a person of ordinary skill would have removed and
`replaced those side chains with zwitterionic side chains, how the skilled
`artisan would have done so, and whether the skilled artisan would have had
`a reasonable expectation of success in doing so. See Intelligent Bio-Sys,
`Inc., 821 F.3d at 1367. Moreover, as Patent Owner asserts, Inganas teaches
`adding its zwitterionic functionalities to a thiopene unit. Prelim. Resp. 46–
`47; Ex. 1006, 3:1–4. In view of that teaching, and the presence of a thiopene
`unit in the DBT unit of Hou’s copolymer, the Petitioner has not explained
`persuasively why a person of skill in the art would have had a reasonable
`expectation of success modifying Hou’s copolymer in a different fashion,
`i.e., by appending the zwitterionic side chains instead to the fluorene unit of
`the copolymer. For at least those reasons, based on the information
`presented, we determine that Petitioner has not shown a reasonable
`likelihood of prevailing in showing the unpatentability of independent claim
`1, or dependent claims 20, 22, 25, and 26, over the proposed combination of
`Hou and Inganas.
`
`
`
`
`15
`
`

`

`IPR2018-01367
`Patent 8,835,113 B2
`
`
` D. Obviousness over Hou, Bazan, and the Handbook
`Petitioner asserts that claims 1, 3–5, 7, and 27 would have been
`obvious over the combination of Hou, Bazan, and the Handbook. Pet. 46–
`61. Patent Owner disagrees. Prelim. Resp. 51–58. We incorporate our
`discussion of Hou in Section II. C. here.
`1. Bazan
`Bazan is a PCT Application directed to methods and compositions for
`assaying a sample for a target polynucleotide using a polycationic
`multichromophore and a sensor peptide nucleic acid (PNA) complementary
`to the target polynucleotide. Ex. 1033, 2:13–16. Bazan teaches that
`“[b]ecause the target polynucleotide is negatively charged, the sensor PNA
`associates with the polycationic multichromophore, permitting energy
`transfer from the polycationic multichromophore to the signaling
`chromophore, for example via the Förster energy transfer mechanism.” Id.
`at 4:16–19. Bazan describes a preferred embodiment of the invention
`involving the use of a conjugated polymer as the polycationic
`multichromophore, for example poly((9,9-bis(6’-N,N,N-
`trimethylammonium)-hexyl)-fluorene phenylene) with iodide counteranions.
`Id. at 15:15–18. Bazan explains that the “specific molecular structure is not
`critical; any water soluble cationic conjugated polymer with relatively high
`luminescence quantum efficiency can be used.” Id. at 15:21–23.
`2. The Handbook
`Chapter 1 of the Handbook discusses fluorophores and their amine-
`reactive derivatives. Ex. 1005, Table of Contents. Section 1.2 of that
`chapter describes kits for labeling proteins and nucleic acids with a
`fluorescent dye. Id. at 14. In particular, the Handbook describes three
`
`
`
`
`16
`
`

`

`IPR2018-01367
`Patent 8,835,113 B2
`
`nucleic acid labeling kits: ARES DNA Labeling Kits, Alexa Fluor
`Oligonucleotide Amine Labeling Kits, and ULYSIS Nucleic Acid Labeling
`Kits. Id. at 18.
`
`3. Analysis
`Petitioner asserts that Hou, Bazan, and the Handbook teach all of the
`elements of claim 1. Pet. 47. In particular, we focus on Petitioner’s reliance
`on the combined teachings to yield the elements of the “aggregation sensor”
`recited in claim 1.
`Petitioner asserts that “Hou’s conjugated copolymers meet all the
`requirements of the conjugated polymer included within the aggregation
`sensor of claim 1,” except that “Hou’s polymers are not used as an
`‘aggregation sensor’ to detect or analyze an aggregant.” Id. According to
`Petitioner, “Bazan used polyfluorene copolymers like Hou’s in exactly such
`[a] manner.” Id. Specifically, Petitioner asserts that “Bazan teaches
`solubilization of polyfluorene copolymers, like Hou’s with cationic side-
`chains, and use of these conjugated copolymers as FRET donors to detect
`DNA.” Id. Petitioner asserts that a person of ordinary skill in the art would
`have had a reason “to use Hou’s conjugated copolymer in Bazan’s FRET-
`based DNA detection assay, equipped with the Alexa Fluor®750
`fluorophore of the Handbook, and to add Bazan’s cationic side chains to
`Hou’s copolymer.” Id. at 49.
`Petitioner asserts that a skilled artisan would have modified Hou’s
`copolymer to include cationic side chains because “Bazan taught that the
`cationic functionalities on [its] polymer allowed it to bind to DNA and that
`the polymer should be ‘water-soluble’ in order to work properly in aqueous
`assays.” Id. at 52 (citing Ex. 1033, 17:3–6, 17:21–23); Ex. 1002 ¶ 147.
`
`
`
`
`17
`
`

`

`IPR2018-01367
`Patent 8,835,113 B2
`
`Therefore, Petitioner asserts that a skilled artisan “would have solubilized
`Hou’s copolymers with Bazan’s cationic functionalities” to render the
`copolymers useful for Bazan’s assay. Id. (citing Ex. 1002 ¶ 147).
`According to Petitioner and Dr. Schanze, doing so would have been routine
`to such artisans. Id. at 54 (citing Ex. 1002 ¶¶ 151–154). In support of that
`assertion, Petitioner and Dr. Schanze rely upon Bazan’s reference to Stork9
`for details on the synthesis of the copolymer. Id. at 55 (citing Ex. 1006,
`24:30). According to Petitioner and Dr. Schanze, Stork teaches a skilled
`artisan how to prepare “Hou’s copolymers with fluorine units comprising the
`solubilizing functionalities of Bazan.” Id. (citing Ex. 1002 ¶ 152).
`Patent Owner asserts that Petitioner and Dr. Schanze have “not
`presented a credible method for adding Bazan’s side chains to Hou’s
`fluorine units” because Hou’s copolymers already include dioctyl side
`chains at position 9 of the fluorene unit. Prelim. Resp. 58. Patent Owner
`asserts that Petitioner does not suggest “that a POSA would have been
`motivated to remove Hou’s dioctyl side chains to replace them with Bazan’s
`cationic side chains, nor does [Petitioner] explain how a POSA would
`accomplish this.” Id.
`Having considered the arguments and evidence, we find Patent
`Owner’s arguments to have merit. In particular, we agree with Patent
`Owner that Petitioner has not adequately demonstrated that a person of
`ordinary skill in the art would have had a reasonable expectation of
`
`
`
` 9
`
` Stork et al., Energy Transfer in Mixtures of Water-Soluble Oligomers:
`Effect of Charge, Aggregation, and Surfactant Complexation, 14 ADV.
`MATER. 361-366 (2002) (“Stork”) (Ex. 1081).
`
`18
`
`
`

`

`IPR2018-01367
`Patent 8,835,113 B2
`
`successfully modifying Hou to include cationic side chains in the manner
`disclosed in Bazan. According to Petitioner, a person of ordinary skill in the
`art would have understood from Bazan that in order for Hou’s copolymers to
`be useful as aggregation sensors in the method disclosed by Bazan, Hou’s
`copolymers would need to be modified to include cationic side chains. Pet.
`52. Indeed, Petitioner asserts that “Bazan taught that the cationic
`functionalities on [its] polymer allowed it to bind to DNA and that the
`polymer should be ‘water-soluble’ in order to work properly in aqueous
`assays.” Id. (citing Ex. 1033, 17:3–6, 17:21–23); Ex. 1002 ¶ 147. Thus, at a
`minimum, Petitioner’s combination of Hou and Bazan requires a person of
`ordinary skill in the art to have had a reasonable expectation of successfully
`modifying Hou’s cop

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket